A transplantable TH-MYCN transgenic tumor model in C57Bl/6 mice for preclinical immunological studies in neuroblastoma

Immunology and Microbiology

• Immunotherapy 100%
• Mouse Model 100%
• Natural Killer Cell 100%
• Transgenics 100%
• Immunology 100%
• Neuroblastoma Cell 66%
• Syngenic 66%
• Tumor Antigen 66%
• Monoclonal Antibody 66%
• Wild Type 33%
• Tumor Cell 33%
• Myeloid 33%
• Regulatory T Cell 33%
• Immune Response 33%
• Wild Type Mouse 33%
• Cell Line 33%
• Adaptive Immune System 33%
• Immunogenicity 33%
• MHC Class I 33%
• Immunity 33%
• Tumor-Associated Macrophage 33%
• Antibody-Dependent Cell-Mediated Cytotoxicity 33%
• Recombination-Activating Gene 1 Knockout Mouse 33%

Keyphrases

• Neuroblastoma 100%
• Tumor Model 100%
• Transgenic 100%
• Transplantable 100%
• Immunological Study 100%
• Tumor 37%
• Mouse Model 37%
• Natural Killer Cells 37%
• Immunobiology 37%
• Tumor Growth 25%
• Syngeneic 25%
• Tumor Antigen 25%
• RAG1 25%
• Human Neuroblastoma 25%
• TH-MYCN Transgenic Mouse 25%
• Neuroblastoma Cells 12%
• Neuroblastoma Tumor 12%
• Tumor Cells 12%
• Immune Response 12%
• Disialoganglioside 12%
• Anti-GD2 Antibody 12%
• Favorable Outcome 12%
• Human Neuroblastoma Cells 12%
• Adaptive Immune Response 12%
• Immunological Characteristics 12%
• Regulatory T (Treg) Cells 12%
• Combined Modality Therapy 12%
• Advanced Disease 12%
• Monoclonal Antibody 12%
• MHC Class I 12%
• Antibody-based Immunotherapy 12%
• Immune Defense 12%
• Antibody-mediated 12%
• NK1.1 12%
• Tumor-infiltrating Leukocytes 12%
• Tumor-associated Myeloid Cells 12%
• Anti-neuroblastoma 12%
• Low Immunogenicity 12%